Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media

ClinicalTrials.gov ID: NCT02044341

Public ClinicalTrials.gov record NCT02044341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Children ages 2 months to less than 19 years old, who have been diagnosed with a middle ear infection may receive either medicated ear drops (AR01) or glycerin (placebo) ear drops. The patient or caregiver will measure the amount of ear pain before and after the ear drops to establish if the medicated ear drops decrease the amount of pain more than the placebo ear drops. The subject may leave the clinic 60 minutes after the first dose. The ear drops can be used up to 4 days, as needed for ear pain.

Study identification

NCT ID
NCT02044341
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arbor Pharmaceuticals, Inc.
Industry
Enrollment
304 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2013 (Type not available)
Primary completion
Mar 2014 (Actual)
Completion
Mar 2014 (Actual)
Last update posted
Apr 8, 2015

2013 – 2014

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Shoals Medical Trials, Inc. Sheffield Alabama 35660 —
SC Clinical Research, Inc Tuscon Arizona 85745 —
NEA Baptist Clinic Jonesboro Arkansas 72401 —
So Cal Clinical Research Group Bellflower California 90706 —
Southland Clinical Research Center Fountain Valley California 92708 —
Madera Family Medical Group Madera California 93637 —
Colorado Springs Health Partners /Clinical Research Advantag Colorado Springs Colorado 80902 —
Pharma Research International, Inc Naples Florida 34102 —
SCORE Physician Alliance, LLC St. Petersburg Florida 33710 —
The Iowa Clinic, Pc West Des Moines Iowa 50266 —
Heartland Research Associates, LLC Wichita Kansas 67205 —
Kentucky Pediatric / Adult Research Bardstown Kentucky 40004 —
Brownsboro Park Pediatrics Louisville Kentucky 40207 —
Michael W. Simon, MD, PSC Nicholasville Kentucky 40356 —
Virgo-Carter Pediatrics Silver Spring Maryland 20910 —
Hennepin County Medical Center -Department of Emergency Medicine Minneapolis Minnesota 55415 —
Clinical Research Center Las Vegas Nevada 89104 —
Valley Stream Pediatrics Valley Stream New York 11580 —
White Oak Family Physicians Asheboro North Carolina 27203 —
UNC Children's Hospital - General Pediatrics and Adolescent Medicine Chapel Hill North Carolina 27516 —
Hometown Urgent Care and Research Center (Dayton) Dayton Ohio 45425 —
PMG Research of Bristol Bristol Tennessee 37620 —
DiscoveResearch, Inc. Byran Texas 77802 —
Research Across America - Dallas Dallas Texas 75234 —
Pediatric Healthcare of Northwest Houston, PA Tomball Texas 77375 —
J. Lewis Research, Inc/Jordan River Family Medicine Jordan Utah 84095 —
FirstMed Salt Lake City Utah 84109 —
Lewis Research, Inc/Foothill Family Clinic Salt Lake City Utah 84109 —
Wee Care Pediatrics Syracuse Utah 84075 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02044341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2015 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02044341 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →